Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 4 SUPPL. S1, 2000, Pages 101-106

  Morrissey, Ian ^a   George, John T ^a  

^a GR Micro Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SN 265805; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PURIFICATION; ESCHERICHIA COLI; MOLECULAR CLONING; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; FLUOROQUINOLONES; NAPHTHYRIDINES; STREPTOCOCCUS PNEUMONIAE;

EID: 0034115274     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61, 377-92.
2. Gellert, M., Mizuuchi, K., O'Dea, M. H. & Nash, H. A. (1976). DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proceedings of the National Academy of Sciences, USA 73, 3872-6.
3. Kato, J., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S. & Suzuki, H. (1990). New topoisomerase essential for chromosome segregation in E. coli. Cell 63, 393-404.
4. Morrissey, I. & George, J. T. (1999). Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins. Antimicrobial Agents and Chemotherapy 43, 2579-85.
5. Pan, X.-S. & Fisher, L. M. (1999). Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification and differential inhibition by fluoroquinolones. Antimicrobial Agents and Chemotherapy 43, 1129-36.
6. Cormican, M. G. & Jones, R. N. (1997). Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone. Antimicrobial Agents and Chemotherapy 41, 204-11.
7. Fuentes, F., Marco, F., Giménez, M., Gomez-Lus, R., Prieto, J. & Aguillar, L. (1999). Comparative in vitro activity of gemifloxacin against S. pneumoniae clinical isolates exhibiting high ciprofloxacin MICs. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 125-6 (Abstract P385).
8. Morrissey, I. & George, J. T. (2000). The bactericidal activity of gemifloxacin (SB 265805) and other fluoroquinolones against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 45, Suppl. S1, 107-110.
9. Felmingham, D. & Washington, J. (1999). Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. Journal of Antimicrobial Chemotherapy 11, Suppl. 1, 5-21.
10. Broskey, J., Coleman, K., Gwynn, M., Holmes, D., Ingraham, K., Lunsford, D. et al. (1999). Quinolone resistance mechanisms in 17 strains of S. pneumoniae and comparative susceptibility to gemifloxacin. Journal of Antimicrobial Chemotherapy 44, Suppl. A, 127 (Abstract P391).
11. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA.
12. Pan, X.-S. & Fisher, L. M. (1996). Cloning and characterisation of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. Journal of Bacteriology 178, 4060-9.
13. Balas, D., Fernández-Moreira, E. & De La Campa, A. G. (1998). Molecular characterisation of the gene encoding the DNA gyrase A subunit of Streptococcus pneumoniae. Journal of Bacteriology 180, 2854-61.
14. Nakamura, S., Nakamura, M., Kojima, T. & Yoshida, H. (1989). gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrobial Agents and Chemotherapy 33, 254-5.